Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

888
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
888
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

712
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
712
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

127
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
127
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

587
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
587

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charting the future of ACMI: a report from the 2025 ACMI symposium.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Assessing the Effectiveness and Scalability of Fast Healthcare Interoperability Resource-Based Granular Data Segmentation Technology.

Applied clinical informatics·2026
Same author

Balancing Privacy, Trust, and Equity: Patient Perspectives on Substance Use Disorder Data Sharing.

International journal of environmental research and public health·2025
Same author

FHIR Granular Sensitive Data Segmentation.

Applied clinical informatics·2025
Same author

Empowering diversity: striving for inclusivity by leveraging the American Medical Informatics Association's "For Your Informatics" Podcast.

JAMIA open·2024
Same author

Special issue on Human-Centered Artificial Intelligence for One Health.

Artificial intelligence in medicine·2024

Related Experiment Video

Updated: May 2, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Ontological approach to reduce complexity in polypharmacy.

Susan Farrish1, Adela Grando2

  • 1United States Air Force, Air Force Medical Support Agency, Medical Informatics Division, Joint Base San Antonio Lackland, Texas.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|February 20, 2014
PubMed
Summary
This summary is machine-generated.

Medication complexity impacts patient adherence and outcomes. This study introduces an ontology-based decision aid to automatically assess regimen complexity and suggest simplifications for improved patient care.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K

Related Experiment Videos

Last Updated: May 2, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K

Area of Science:

  • Biomedical Informatics
  • Pharmacology
  • Clinical Decision Support

Background:

  • Patient non-compliance with complex medication regimens leads to poor health outcomes.
  • Healthcare providers often lack awareness of prescription complexity.
  • Existing methods for calculating regimen complexity lack widely available automated tools.

Purpose of the Study:

  • To explore the use of ontologies for reducing medication complexity.
  • To develop and test an ontology-based decision aid for assessing and simplifying patient medication regimens.

Main Methods:

  • Developed an Ontology for modeling drug-related knowledge and complexity scoring.
  • Tested the Ontology using patient data from the University of California San Diego Epic database.
  • Built a decision aid to compute regimen complexity and recommend simplification strategies.

Main Results:

  • The developed ontology successfully modeled drug-related knowledge.
  • The decision aid effectively computed medication regimen complexity.
  • The system provided recommendations for reducing complexity.

Conclusions:

  • Ontology-based approaches can effectively model and manage medication complexity.
  • Automated decision aids can assist providers in simplifying regimens.
  • Reducing medication complexity has the potential to improve patient adherence and outcomes.